Corporate & Investor Presentation

Long-term CPAP treatment decreases mortality rates and reduces the risk of comorbidities Recent prospective cohort study from the UK published in ERJ Open Research reconfirms treating OSA with CPAP improves health outcomes 30 year study duration 4,502 diagnosed OSA patients 15 year average follow-up time Those who did not use CPAP were 5.63x more likely to die than a long-term (>5 years) CPAP user The study also reconfirms with new data that untreated OSA leads to a greater risk in developing: Dodds et al. ERJ Open Res 2020 43 2021 ResMed | Corporate & Investor Presentation - updated 29APR21 Myocardial Infarction (heart attack) Type 2 Diabetes Mellitus Ischemic Heart Disease ResMed

View entire presentation